In our study, we proposed a novel prognostic marker that combines the prognostic relevance of already well-established clinical parameters (T classification, N classification, and tumor invasion with regars to the OL), one inflammation marker (NLR), and two markers of malnutrition and cachexia (BMI and albumin). The gene discussed is ALB; the disease is neoplasm.